66 Cleared. One Courtroom Left.

Analyst Targets (PSKY)

• Benchmark: Buy, $16.00 (lowered from $19.00)
• BofA Global Research: Underperform, $9.00 (lowered from $11.00)
• TD Cowen: Hold, $8.00 (lowered from $13.00)
• UBS: Sell, $8.00 (lowered from $10.00)
• Guggenheim: Neutral, $12.00
• Wells Fargo: Underweight, $7.00
• Consensus (20 analysts): Hold, ~$11.77 average target

Hook

Hey there, bargain hunter. The UK Competition and Markets Authority cleared Paramount Skydance’s proposed acquisition of Warner Bros. Discovery on August 6, 2026. Sixty-six jurisdictions have now either approved this deal or declined to challenge it on competition or foreign investment grounds. The DOJ blessed it in June. The EU signed off with a relatively minor concession on European film distribution. Every major overseas regulator has said yes.

The deal is still not closing. That tells you exactly where the risk lives.

A coalition of 12 state attorneys general, led by California’s Rob Bonta, filed suit in July 2026 to block the $110 billion transaction. Judge Araceli Martinez-Olguin set the antitrust trial to begin March 2, 2027, with the case expected to run 12 court days, wrapping by March 19. Paramount agreed to hold the merger until five days after a trial verdict or June 1, 2027, whichever is earlier. The ticking fee activates October 1. The meter is 53 days from running.

Scoreboard

PSKY closed at $9.08 on August 6, 2026, after trading in a range of $8.71 to $9.26 that session. The 52-week range runs from $7.62 to $20.86. The stock has lost roughly 30% of its value in 2026 to date, per Deadline’s reporting in July. The consensus target of $11.77 implies 40% upside from current levels. That gap is not an obvious gift. It is the market pricing a complicated probability tree.

Separately, Paramount reported Q2 2026 earnings on August 4. The numbers were mixed in a way that illuminates the standalone story.

• Total Q2 revenue: $6.91 billion
• Full-year 2026 revenue guidance: $30 billion (4% growth year over year)
• Q2 net income: $41 million, down from $57 million in Q2 2025
• Q2 adjusted EPS: $0.04 vs. consensus of $0.17
• Adjusted EBITDA guidance (raised): $3.8 billion to $3.9 billion for full year
• Direct-to-consumer revenue: Up 9% to $2.47 billion; Paramount+ alone up 16%
• Paramount+ subscribers: 81.6 million global, up from 79.6 million in Q1
• TV Media revenue: Down 9% to $3.13 billion; advertising down 14% year over year
• Studios revenue: Up 16% to $1.31 billion; segment returned to adjusted EBITDA profitability
• Q3 revenue guidance: $6.95 billion to $7.15 billion; Paramount+ subscriber additions guided “flattish” quarter over quarter

Streaming is pulling in the right direction. Linear television is not. That tension is not new, but it is the permanent backdrop against which every merger scenario plays out.

The Real Reason

The UK clearance was priced in. Culture Secretary Lisa Nandy had signaled a possible intervention earlier in the process, but her department ultimately determined that Paramount’s agreed protections, covering editorial independence for UK news operations and the continued separation of linear and on-demand services in the market, were sufficient. The tail risk passed. The stock moved a few percent. Then the market turned its attention back to Oakland.

What the market is really pricing is the ticking fee, the breakup risk, and the trial outcome. The DOJ cleared this deal. Sixty-five other jurisdictions cleared it. Twelve state attorneys general did not. Their antitrust argument centers on three specific markets: basic cable programming, tentpole theatrical releases, and wide-release theatrical distribution. They allege the combined company would control two of the top three cable programmers and two of the top five film distributors. Fortune reported that the post-merger Herfindahl-Hirschman Index for domestic theatrical distribution would land near 1,960, above the DOJ’s own 1,800 threshold for a highly concentrated market.

Paramount’s counter is blunt: the lawsuit has no basis in fact, economics, or antitrust law. The company has called it one of the weakest merger challenges in modern antitrust history, and has pointed to the near-unanimous global approvals as evidence that the antitrust framing is politically motivated. CEO David Ellison addressed the subtext directly in a New York Times op-ed, stating that the underlying fight is about CNN’s future editorial independence, not market structure.

Both arguments will be tested starting March 2. The clock costs money either way.

Deep Dive: What This Business Is

Paramount Skydance came together in the first half of 2025 when Skydance Media, backed by Larry Ellison and a consortium of Middle Eastern sovereign funds, completed an $8 billion acquisition of legacy Paramount. The resulting entity operates across three segments: TV Media (CBS, cable networks, affiliate revenue), Direct-to-Consumer (Paramount+, BET+, Pluto TV), and Studios (Paramount Pictures, theatrical, licensing).

The WBD acquisition would layer in Warner Bros. studio, HBO and Max, CNN, Discovery’s factual cable portfolio, and Warner’s international distribution footprint. The combined entity would hold one of the broadest content libraries in the industry, spanning news, scripted premium drama, film, kids, factual, and sports. The strategic pitch is scale against Netflix, Amazon, and Disney. That pitch has survived 66 regulatory reviews intact.

What the deal does not solve on its own is the debt load. TheStreet and SEC filings indicate the combined company would carry roughly $80 billion in debt at close. The Ellison family-linked equity commitments and Middle Eastern sovereign capital are backstopping a capital structure that requires synergies to work. The company has guided investors toward more than $6 billion in eventual cost efficiencies from the combination. It has already achieved over $2.7 billion in run-rate efficiencies from the Skydance-Paramount integration alone, with a $3 billion-plus target by year-end 2026. That is real progress. But the WBD synergies are still theoretical until a judge rules.

The Numbers That Matter Now

The earnings figures above describe the standalone business. The merger mechanics below describe the deal’s cost of delay.

• Deal size: $110 billion enterprise value; WBD shareholders receive $31.00 per share in cash plus ticking consideration if closing occurs after September 30, 2026
• Ticking fee rate: $0.25 per WBD share per 90-day period, accruing daily at approximately $0.00277778 per share per day from October 1; roughly $7 million per day in aggregate terms
• Ticking fee per quarter: Approximately $650 million per quarter
• Ticking fee exposure to June 2027: CNBC has reported a delay through June 2027 could add roughly $1.7 billion to the deal price
• Company-guided incremental financing cost: The Q2 2026 earnings call referenced approximately $190 million in incremental financing costs if the deal closes by June 2027, including bridge fees and ticking fees, per the CFO’s commentary
• Breakup fee: $7 billion owed by Paramount to WBD if the deal falls apart due to regulatory failure
• Trial dates: March 2 to approximately March 19, 2027; pre-trial conference February 24, 2027; joint case management statement due August 13, 2026
• Outside date: Paramount agreed not to close the transaction until five days after a verdict or June 1, 2027, whichever is earlier
• Pro forma debt at close: Approximately $80 billion, per TheStreet reporting referencing SEC filings

The gap between the $190 million the company cited on the earnings call and the $1.7 billion CNBC calculated for a full delay to June 2027 is worth noting. The company’s figure likely reflects assumptions about an earlier resolution. The outer case is materially worse. Settlement is the variable that determines which number applies.

Is It Cheap?

PSKY at $9.08 sits at roughly 56% of its 52-week high of $20.86. The consensus target of $11.77 prices in a deal close but not a clean one. The bear targets at $7.00 (Wells Fargo) and $8.00 (UBS) are essentially standalone valuations with full deal-failure risk embedded. The lone bull, Benchmark at $16.00, requires both a trial win and an unencumbered integration path.

On its own, Paramount Skydance is a company where streaming revenue grew 16% in Q2, TV Media fell 9%, and the total company posted a thin $41 million in net income on $6.91 billion in revenue. Full-year EBITDA of $3.8 to $3.9 billion implies roughly 13% margins on $30 billion in sales. That is not a cheap multiple for a structurally pressured media company without WBD’s scale. The deal premium is the entire investment argument. Without it, the stock is a mid-tier media business in a sector where Morningstar has explicitly noted that content is too dispersed among too many streaming services for a subscale platform to reach the subscriber base and pricing it needs.

The arb math: consensus target of $11.77 minus current price of $9.08 equals roughly $2.69 of upside, or about 30%. Against a trial that runs March 2 to 19, then a findings period through April 5, 2027, the time value of that spread is carrying a non-trivial legal risk. That is what makes this a proper arb situation rather than an obvious value play.

Bull / Base / Bear

Bull

Settlement before October 1. If Paramount and the state attorneys general reach an agreement before the ticking fee activates, the deal closes on the original timeline, the $7 million daily meter never runs, and roughly $1.7 billion in fee exposure evaporates. The August 13 joint case management statement is the first public document that could signal whether settlement discussions have begun. A settlement-friendly tone in that filing would be the earliest possible positive catalyst. PSKY’s consensus target of $11.77 would be immediately in play, and the combined entity begins integration ahead of schedule.

Base

Paramount wins at trial, deal closes in Q2 2027. The ticking fee runs from October 1, 2026, through a post-verdict close, and the incremental cost lands somewhere between the company’s $190 million guidance and CNBC’s $1.7 billion outer estimate depending on the exact timing. Synergies begin accruing, the $6 billion efficiency target gives the balance sheet a glide path, and the combined entity starts competing meaningfully with Netflix and Disney in premium streaming. PSKY trades in the $8 to $12 range through the overhang period, with the upper end of that range accessible only if trial commentary turns favorable.

Bear

The court rules for the state attorneys general, or the merger agreement expires without resolution. A failed deal triggers the $7 billion breakup fee owed to WBD, per the merger agreement. PSKY reverts to a standalone mid-scale media company carrying a heavily leveraged balance sheet from the original Skydance transaction, with TV advertising down 14% year over year, linear distribution revenue eroding, and no streaming scale sufficient to offset both. Wells Fargo’s $7 target and UBS’s $8 target are pricing this outcome. The 52-week low of $7.62 is the technical reference for this scenario.

Action Plan

This is an event-driven arb with a defined timeline and a hard cost structure. It is not a value buy on business fundamentals. Position sizing should reflect that.

• Existing holders: Hold through August 13. Read the joint case management statement closely for settlement signals. If the language is purely procedural with no reference to ongoing discussions, the October 1 ticking fee is effectively confirmed. Reassess position size before that date.
• New entrants, conservative posture: Wait. The current spread between $9.08 and the $11.77 consensus does not compensate adequately for the combination of a six-month litigation overhang, a $7 billion downside if the deal breaks, and daily fee accrual that makes the acquirer’s balance sheet progressively less attractive with each passing quarter. There is no urgency before August 13.
• New entrants, aggressive posture: A small starter position in the $8.50 to $9.00 range captures meaningful upside if the August 13 filing shows settlement momentum. Scale only on confirmation. The stop is a break below the 52-week low of $7.62.
• Scale-in framework: First tranche on a settlement signal in the August 13 filing; second tranche after the February 24 pre-trial conference, if trial posture favors Paramount; third tranche post-verdict if Paramount prevails. Do not front-run the verdict with a full position.

Cheap Investor Scorecard

• August 13, 2026: Joint case management statement due. Settlement language or absence of it is the immediate tell.
• October 1, 2026: Ticking fee activates. Approximately $7 million per day, or $650 million per quarter, begins accruing to WBD shareholders.
• Paramount+ subscriber trend: Q3 guidance called for “flattish” net adds. Actual result versus that guidance is the cleanest read on the standalone DTC story.
• TV Media advertising: Down 14% in Q2. Monitor the rate of decline. An acceleration below that level makes the standalone case worse in a no-deal scenario.
• Debt offer and exchange deadline extensions: Each extension signals the timeline is slipping. Track these closely; they are advance warning on closing delays.
• Oracle credit-default swaps: Fortune reported Oracle’s CDS hit their highest levels since 2008. The Ellison family backstop is a key pillar of the equity commitment. Any deterioration in Oracle’s balance sheet capacity is relevant to deal financing.
• February 24, 2027: Pre-trial conference. Final legal posture before trial opens. The tone of pre-trial submissions often telegraphs which side is more confident.
• Trial period, March 2 to 19, 2027: Daily coverage from the Oakland courtroom. Expert witnesses on the HHI market concentration argument will be the pivot point.
• April 5, 2027 deadline: Proposed findings of fact and conclusions of law from both parties due. The court’s timeline to verdict runs from here.
• $7 billion breakup fee: This is the hard floor on downside analysis. Every scenario must price the probability that Paramount writes that check.

Bottom Line

The UK clearance is a milestone. It is not a catalyst. Sixty-six jurisdictions approved this deal. The one that matters is a single federal courtroom in Oakland, where Judge Araceli Martinez-Olguin has set trial for March 2, 2027.

If Paramount wins at trial and closes by June 2027, the arb spread resolves in the buyer’s favor, the ticking fee cost is absorbed into a deal whose synergy case still works, and PSKY trades materially above today’s $9.08. If the deal breaks, Paramount writes a $7 billion check to WBD, faces a standalone balance sheet that carries the original Skydance leverage without the scale to offset linear declines, and the stock finds a new floor well below the 52-week low.

The Q2 earnings showed a company whose streaming segment is genuinely gaining ground. Paramount+ at 81.6 million subscribers, 16% revenue growth on the DTC line, and a best-ever retention quarter are real data points. But the standalone business earns $41 million in net income on $6.91 billion in revenue. The deal is the entire investment case. The clock starts October 1.

Watch August 13 first. Everything else is sequenced behind it.

The Cheap Investor